Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Jubilant Flame International, Ltd

CIK: 15173892 Annual ReportsLatest: 2025-04-04

10-K / April 4, 2025

Revenue:N/A
Income:-$59,672

10-K / May 7, 2024

Revenue:N/A
Income:-$67,365

10-K / April 4, 2025

Company Summary: Jubilant Flame International, Ltd.

Overview

  • Founded: September 29, 2009, under the name Liberty Vision, Inc.
  • Incorporation: Nevada
  • Current Name: Jubilant Flame International, Ltd. (since August 18, 2015)
  • Location: Room 508, T1N Vi Park, 360 Xin Long Road, Shanghai, China, 201101

Business Activity and Evolution

  • Initial Business: Provided web development and marketing services through a wholly owned subsidiary.
  • Disposal of Subsidiary: In December 2012, the company disposed of this subsidiary.
  • Original Focus: Developing and marketing medical products including Bone-Induction Artificial Bone and Vacuum Sealing Drainage under a BioMark license.
  • Transition to Cosmetics: Starting in Q4 FY2018, the company began promoting and selling cosmetic products in the U.S., specifically the "Acropass" series.
    • Products: Hydrocolloid patches with dissolving microstructures containing hyaluronic acid and epidermal growth factor (EGF).
    • Sale Method: Sold directly online via own website and Amazon.
    • Supplier: Rubyfield Holdings Limited (Chinese company owned by the CEO).
    • Distribution: Managed through an agreement with a third-party manager, fulfilling orders in the U.S.
  • Ceased Cosmetic Sales: Began in early 2020, with no revenue generated from cosmetics thereafter.
  • New Business Focus (from 2020): Providing technical support services related to the development of nutritionally oriented foods.
    • Products Supported: Sea-Buckthorn and Organic Sprouting Powder.
    • Revenue: No revenue has been reported from this new business line as of FY2025.

Operations and Market

  • Customer Base: No specific number of customers stated; sales were conducted online targeted toward U.S. consumers.
  • Employees: 5 employees; primarily officers and directors managing operations.
  • Revenue & Income:
    • Revenue: $0 for FY2024 and FY2025.
    • Net Loss:
      • FY2024: $67,365
      • FY2025: $59,672
  • Market: The skincare and cosmetic market in the U.S. is highly competitive with large multinational competitors, smaller brands, and online skin care specialty sites.

Financial & Business Status

  • Financial Condition:
    • Total Assets (FY2025): $12,925
    • Total Liabilities (FY2025): $1,369,510
    • Working Capital Deficit: Approx. $1.36 million as of FY2025.
    • No revenue from product sales in FY2025; primarily operational expenses.
    • Loan: $763,424 owed to the CEO as of FY2025.
  • Employees: No salaried employees other than officers and directors; no formal retirement or benefit plans.
  • Regulatory: Products regulated under U.S. law (FD&C Act & FPLA) as cosmetics, but no premarket approval needed apart from color additives.
  • Ownership & Stock:
    • 19,985,708 shares outstanding as of April 2025.
    • Mainly held by the company's officers and a few directors.
    • No dividends paid or expected in the foreseeable future.

Summary of Key Activities

  • Transitioned from medical device products to cosmetics, then ceased cosmetics sales.
  • Currently offers technical support services for nutritionally oriented foods with no reported revenue.
  • No current product sales, no active affiliates or distributors, and limited operational scale.
  • Financially, it operates at a loss with minimal assets and significant liabilities primarily owed to the CEO and related parties.

Note: The company’s financials and operations indicate a small-scale, privately held enterprise focusing on niche product development and technical consulting rather than active product sales.